Diese Präsentation wurde erfolgreich gemeldet.
Die SlideShare-Präsentation wird heruntergeladen. ×

Nzovu Ulenga, Tanzania HIV/AIDS Progress: Successes, Challenges, and Lessons Learned

Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Wird geladen in …3
×

Hier ansehen

1 von 7 Anzeige

Nzovu Ulenga, Tanzania HIV/AIDS Progress: Successes, Challenges, and Lessons Learned

Herunterladen, um offline zu lesen

October 7, 2019

On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.

For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar

October 7, 2019

On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.

For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar

Anzeige
Anzeige

Weitere Verwandte Inhalte

Diashows für Sie (16)

Ähnlich wie Nzovu Ulenga, Tanzania HIV/AIDS Progress: Successes, Challenges, and Lessons Learned (20)

Anzeige

Weitere von The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics (20)

Aktuellste (20)

Anzeige

Nzovu Ulenga, Tanzania HIV/AIDS Progress: Successes, Challenges, and Lessons Learned

  1. 1. TANZANIA HIV/AIDS PROGRESS: SUCCESSES, CHALLENGES, AND LESSONS LEARNED Nzovu Ulenga, PhD Management and Development for Health (MDH)
  2. 2. Management and Development for Health (MDH) Management and Development for Health (MDH) is an independent Tanzanian public health NGO currently supporting over 500,000 HIV patients in Tanzania Established by Harvard School of Public Health in partnership with Muhimbili University of Health and Allied Sciences, and Dar es Salaam Region, with support from Track 1 PEPFAR Funding Vision: A healthy and prosperous society Mission: To support, promote and address public health priorities through evidence based and innovative interventions in collaboration with the government, partners, stakeholders and the community
  3. 3. HIV PREVALENCE IN TANZANIA Source: NBS Tanzania HIV Impact Survey 2016 – 2017 & UNAIDS •HIV prevalence in Tanzania is estimated at 5.1% •Women aged 15 to 49 HIV prevalence 5.7 % •Men aged 15 to 49 HIV prevalence 3.5 % •Young women HIV prevalence 2.2 % • Young men HIV prevalence 1.2% Adults and children 72 000 Adults aged 15 and over 64 000 Women aged 15 and over 36 000 Men aged 15 and over 27 000 Children aged 0 to 14 8600 HIV incidence per 1000 population (adults 15-49) 2.5% HIV incidence per 1000 population (all ages) 1.41 % New HIV infection
  4. 4. PEOPLE LIVING WITH HIV IN TANZANIA Source: NBS Tanzania HIV Impact Survey(THIS) 2016 – 2017 and UNAIDS People living with HIV 1 600 000 People living with HIV who know their status 1 200 000 Percent of people living with HIV who know their status 78% People living with HIV who are on ART 1 100 000 Percent of people living with HIV who are on ART 71% People living with HIV who have suppressed viral loads 960 000 Percent of people living with HIV who have suppressed viral loads 62%
  5. 5. ART COVERAGE IN TANZANIA • Adults and children 71% • Adults aged 15 and over 72% • Women aged 15 and over 82% • Men aged 15 and over 57% • Children aged 0 to 14 65% 2015 2016 2017 2018 HIV Positives identified 260,435 322,689 282,075 286,159 HIV positives staring ART 169,231 218,303 251,600 269,412 Pregnant women who receive ARV for PMTCT 93% Pregnant women who received ARV for PMTCT (#) 76 967 Pregnant women needing ARV for PMTCT (#) 83 000 HIV Early Infant Diagnosis (HEID) (%) 47% Treatment coverage Elimination of Mother to Child Transmission Increased HIV identification and linkage to care (with 89% VL suppression) Source: UNAIDS, NACP
  6. 6. HIV prevalence among adults 0 1 2 3 4 5 6 7 8 9 Women Overall Men2002 2007 2012 2017 DECREASING HEID POSITIVITY RATE AND HIV PREVALANCE AMONG ADULTS 0.0% 2.0% 4.0% 6.0% 8.0% 10.0% 12.0% 14.0% Y2011 Y2012 Y2013 Y2014 Y2015 Y2016 Y2017 Y2018 PositivityPercent HEID Positivity Rate Percent
  7. 7. Thank you!

×